Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Dec 08, 2008 8:00 AM - Dec 10, 2008 6:00 PM

Practical Guide for Pharmacovigilance: Clinical Trials and Post Marketing

Overview

This is a basic overview course, intended for individuals who have limited experience in pharmacovigilance/drug safety monitoring. The focus will be on pharmacovigilance with traditional medicinal products, both investigational and marketed, intended for human use in clinical trials, in post-marketing studies, and in the healthcare setting following product launch.

Regional developments in the GCC countries will also be highlighted.

Program Committee

  • Gaby L. Danan, MD, PhD
    Gaby L. Danan, MD, PhD Pharmacovigilance Expert
    GLD, France
  • William  Gregory, PhD
    William Gregory, PhD Senior Director, Safety and Risk Management
    Pfizer Inc, United States
  • Bina S. Patel
    Bina S. Patel Director Case Management Group
    GlaxoSmithKline R&D Ltd., United Kingdom
  • Harri Tapani Helajarvi
    Harri Tapani Helajarvi Former Qualified Person for Pharmacovigilance
    Finland

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.